Chidamide Combined With Zimberelimab in the Treatment of Metastatic Triple-negative Breast Cancer Patients
Clinical trial NCT05632848 · COMPLETED
Trial details
- NCT number
- NCT05632848
- Sponsor
- Sun Yat-sen University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-15
- Primary completion
- 2024-10-23
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.